Additionally, Table 3 revealed that several factors were strongly associated with elevated levels of YKL-40 in SLE patients, including longer disease duration, anemia, thrombocytopenia, positive anti-dsDNA and APL ab, all with a p-value < 0.05. This evidence concerns the gene CHI3L1 and anemia.